Replies to post #23908 on MannKind Corp. (MNKD)

[tx_farmer]

Not necessarily. New CEO = new direction. I think their Bio's speak for themselves:

Michael Castagna-
"Entrepreneurial executive with more than 20 years of experience in marketing, sales, medical affairs and strategic development in Fortune 500 companies as well as privately held biotech start-ups. Proven pre-launch and launch experience on over 15 brands in seven distinct disease states with global sales ranging from $250M to over $2Billion. Disciplined, results-driven leader with a personal commitment to developing people and working cross-functionally to achieve core objectives in highly complex and competitive disease states. Specialty disease state expertise: Oncology, Nephrology, GI, Psoriasis, HIV, Hepatitis B & C, Endocrinology, Rheumatoid Arthritis and Infertility."

"Specialties: Strategy, Marketing, Pricing, Managed Care, Clinical Knowledge, Leadership, Generic Industry, Biosimilars, Turn Around and Launch Experience"

Compared to:

Mathew Pfeffer-
"Seasoned financial executive with over 30 years experience, including three public company CFO positions, public company board positions and in-depth knowledge of financing strategies for public companies. Active CPA accreditation and over $1 billion raised to date through well-established Wall Street network."

"Strengths: Strategic planning, mergers and reorganizations (including spin-outs), team building, communications, technical accounting, creative financing"